Primary Record
methotrexate
- In stock
- 9,412 g
- Purity
- 98.7 %
- CAS
- 59-05-2
Compound Identifiers & Properties
- CAS
- 59-05-2
- PubChem CID
- 126941
- SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- Canonical SMILES
- CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
Names & Synonyms
- methotrexate
- Amethopterin
- Rheumatrex
- Ledertrexate
- Abitrexate
- Metatrexan
- Trexall
- Methylaminopterin
- Hdmtx
- Emtexate
- Mexate
- Methotrexatum
- Metotrexato
- Antifolan
- Rasuvo
- Folex
- 59-05-2
- L-Amethopterin
- Amethopterine
- Maxtrex
- Methylaminopterinum
- A-Methopterin
- Methotextrate
- Methoxtrexate
- Farmitrexat
- Medsatrexate
- Methoblastin
- Methopterin
- Methotrexat
- Brimexate
- Emthexate
- Fauldexato
- Emthexat
- Lantarel
- Metrotex
- Novatrex
- Tremetex
- Trexeron
- Trixilem
- Lumexon
- Otrexup
- Texate
- Metex
- A-Methpterin
- Methotrexate Lpf
- Metotressato
- Metolate
- Amethopterin L-
- Xatmep
- Folex Pfs
- Folex-Pfs
- Mexate-Aq
- Methotrexat-Ebewe
- Methotrexate hydrate
- D-Amethopterin
- Methotrexate, L-
- Antifolate
- Antifolates
- Arbitrexate
- Methotrate
- Trexamette
- alpha-Methopterin
- Metoject
- Nordimet
- Ebetrex
- Zlatal
- methotrexat-
- R-methotrexate
- [3H]methotrexate
- D-Methotrexate
- Emtexate pf
- Methotrexate RS
- Extexate;
- JYLAMVO
- Maxtrex;
- Intradose-MTX
- Mexate;
- Methotrexate CRS
- Metotressato [DCIT]
- [3H]-methotrexate
- Methylaminopterin;
- 1dhi
- 1dhj
- 2drc
- 4ocx
- Emtexate high-pot
- Methotrexate, d-
- folic acid antagonist
- REDITREX
- (R)-Methotrexate
- 4-Amino-10-methylfolic acid
- NSC-740
- Prestwick_322
- DMARDs methotrexate
- Otrexup (TN)
- Mexate-Aq Preserved
- Methotrexate 100mg
- METHOTREXATE SODIUM
- Xatmep (TN)
- (+/-)Amethopterin
- N-Bismethylpteroylglutamic acid
- Hydrate, Methotrexate
- An-PDN
- L-METHOTREXATE
- Methotrexate, (R)-
- Methotrexatum [INN-Latin]
- Metotrexato [INN-Spanish]
- OTREXUP PFS
- Folic Acid Antagonists
- Methotrexate (hydrate)
- Methylaminopterin; MTX
- Intrathecal methotrexate
- METHOTREXATE 1G
- RefChem:6017
- YL5FZ2Y5U1
- Acid Antagonist, Folic
- Antagonist, Folic Acid
- Spectrum_001836
- Tocris-1230
- 4kn0
- Methotrexate (Standard)
- Acid Antagonists, Folic
- Antagonists, Folic Acid
- UNII-YL5FZ2Y5U1
- C20H22N8O5
- NCI-C04671
- Metex 6013
- METHOTREXATEHYDRATE
- NSC 740
- Prestwick0_000135
- Prestwick1_000135
- Prestwick2_000135
- Spectrum2_001077
- Spectrum3_000497
- Spectrum4_000616
- Spectrum5_000958
- (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
- Abitrexate (Methotrexate)
- CCRIS 1109
- Methotrexate - Abitrexate
- METHOTREXATE [MI]
- NSC740
- Dicesium Salt Methotrexate
- CL-14377
- DTXSID4020822
- METHOTREXATE [INN]
- METHOTREXATE [JAN]
- 4-Aminomethylpteroylglutamic acid
- CHEBI:44185
- CHEMBL34259
- D(-)-AMETHOPTERIN
- D07ALU
- D0D3DU
- D0SV8E
- DTXCID80822
- Epitope ID:230085
- METHOTREXATE 100G
- HSDB 3123
- METHOTREXATE [HSDB]
- METHOTREXATE [IARC]
- METHOTREXATE [USAN]
- NCIMech_000767
- SCHEMBL3711
- EMT 25,299
- METHOTREXATE(+/-)
- METHOTREXATE [VANDF]
- BIDD:PXR0175
- Lopac0_000020
- MFCD00064370
- KBioGR_001172
- KBioSS_002341
- METHOTREXATE [MART.]
- Methotrexate Methylaminopterin
- ADX-2191
- KSC269O8T
- MLS000049968
- MLS001401431
- MLS002154208
- (+)-4-Amino-10-methylfolic acid
- CL 14377
- DivK1c_000114
- METHOTREXATE [USP-RS]
- METHOTREXATE [WHO-DD]
- METHOTREXATE [WHO-IP]
- Methotrexate Preservative Free
- EINECS 200-413-8
- MTX
- SPBio_001094
- SPBio_002149
- TCMDC-125858
- FBOZXECLQNJBKD-ZDUSSCGKSA-N
- AC1L2R79
- AMY235
- cid_126941
- cid_165528
- GTPL4674
- GTPL4815
- orb1308506
- Folic Acid Metabolism Inhibitors
- MPI-2505
- SCHEMBL12421860
- SCHEMBL23111732
- SCHEMBL29349432
- BDBM18050
- BDBM66082
- CTK1G9789
- Dihydrofolate Reductase Inhibitor
- HMS500F16
- KBio1_000114
- KBio2_002338
- KBio2_004906
- KBio2_007474
- KBio3_001493
- Methotrexate (JP18/USP/INN)
- Methotrexate [USAN:INN:BAN:JAN]
- AOB5585
- Dihydrofolate Reductase Inhibitors
- L01BA01
- L04AX03
- FBOZXECLQNJBKD-UHFFFAOYSA-N
- g301
- Inhibitor, Dihydrofolate Reductase
- MFCD00150847
- NINDS_000114
- Reductase Inhibitor, Dihydrofolate
- BADC-00037
- Bio1_000486
- Bio1_000975
- Bio1_001464
- GLXC-06696
- HMS1568K12
- HMS2095K12
- HMS2233O18
- HMS3260C21
- HMS3414L09
- HMS3678L07
- HMS3712K12
- METHOTREXATE [ORANGE BOOK]
- R 9985
- WR-19039
- 4-amino-N(10)-methylpteroylglutamic acid
- Inhibitors, Dihydrofolate Reductase
- METHOTREXATE [EP MONOGRAPH]
- METHOTREXATE [USP IMPURITY]
- Reductase Inhibitors, Dihydrofolate
- 4-Amino-N10-methylpteroylglutamic acid
- ACT03341
- APC-2002
- BCP13701
- CL14377
- DRG-0024
- KS-00000L8X
- MPI-5004
- MSK10330
- ZINC1529323
- AI3-25299
- Methotrexate [USAN:BAN:INN:JAN]
- METHOTREXATE [USP MONOGRAPH]
- Tox21_110944
- Tox21_300269
- Tox21_500020
- ANW-72813
- CCG-35800
- CID126941
- EBC-12158
- EMT-25299
- HY-14519R
- LS-249
- Methotrexate [USAN:USP:INN:BAN:JAN]
- METHOTREXATUM [WHO-IP LATIN]
- NA2811
- NCGC00025060-04
- s1210
- STL535338
- UN2811
- X 133
- 4-Amino-N(sup 10)-methylpteroylglutamic acid
- AKOS016340329
- C20-H22-N8-O5
- Methotrexate hydrate, 99% - 1G 1g
- Tox21_110944_1
- ACN-050905
- CID:126941
- CS-1732
- DB00563
- J2.334E
- KS-5093
- LP00020
- RTR-020497
- SDCCGSBI-0050009.P003
- WR19039
- CAS-59-05-2
- IDI1_000114
- Methotrexate for peak identification CRS
- R-9985
- SMP2_000020
- NCGC00025060-01
- NCGC00025060-02
- NCGC00025060-03
- NCGC00025060-05
- NCGC00025060-06
- NCGC00025060-07
- NCGC00025060-08
- NCGC00025060-09
- NCGC00025060-10
- NCGC00025060-11
- NCGC00025060-12
- NCGC00025060-13
- NCGC00025060-15
- NCGC00025060-16
- NCGC00254216-01
- NCGC00260705-01
- 133073-73-1
- AJ-26587
- BC202627
- BR-77824
- HY-14519
- SC-19293
- SID:53786964
- SMR000112001
- SMR000449324
- METHOTREXATE SODIUM PRESERVATIVE FREE
- A4347
- EU-0100020
- Folic acid metabolism antagonist methotrexate
- FT-0601523
- FT-0630651
- G-301
- NS00098764
- SW198601-3
- Kyselina 4-amino-N(sup 10)-methylpteroylglutamova
- Methotrexate 1.0 mg/ml in Dimethyl Sulfoxide
- 1771-EP0930075A1
- 1771-EP2269989A1
- 1771-EP2269994A1
- 1771-EP2270001A1
- 1771-EP2270008A1
- 1771-EP2270018A1
- 1771-EP2270505A1
- 1771-EP2272825A2
- 1771-EP2272827A1
- 1771-EP2272832A1
- 1771-EP2275413A1
- 1771-EP2275420A1
- 1771-EP2277565A2
- 1771-EP2277566A2
- 1771-EP2277567A1
- 1771-EP2277568A2
- 1771-EP2277569A2
- 1771-EP2277570A2
- 1771-EP2277865A1
- 1771-EP2277876A1
- 1771-EP2280012A2
- 1771-EP2281563A1
- 1771-EP2281815A1
- 1771-EP2287156A1
- 1771-EP2289892A1
- 1771-EP2289894A2
- 1771-EP2292233A2
- 1771-EP2292280A1
- 1771-EP2292595A1
- 1771-EP2292614A1
- 1771-EP2292615A1
- 1771-EP2292617A1
- 1771-EP2295055A2
- 1771-EP2295416A2
- 1771-EP2295426A1
- 1771-EP2295427A1
- 1771-EP2298743A1
- 1771-EP2298748A2
- 1771-EP2298764A1
- 1771-EP2298765A1
- 1771-EP2298768A1
- 1771-EP2298772A1
- 1771-EP2298778A1
- 1771-EP2298780A1
- 1771-EP2301928A1
- 1771-EP2301933A1
- 1771-EP2305243A1
- 1771-EP2305640A2
- 1771-EP2305642A2
- 1771-EP2305660A1
- 1771-EP2305668A1
- 1771-EP2305671A1
- 1771-EP2305679A1
- 1771-EP2305689A1
- 1771-EP2308833A2
- 1771-EP2308839A1
- 1771-EP2308855A1
- 1771-EP2308861A1
- 1771-EP2311453A1
- 1771-EP2311807A1
- 1771-EP2311808A1
- 1771-EP2311825A1
- 1771-EP2311827A1
- 1771-EP2311829A1
- 1771-EP2311840A1
- 1771-EP2311842A2
- 1771-EP2311850A1
- 1771-EP2314590A1
- 1771-EP2316459A1
- 1771-EP2316832A1
- 1771-EP2316833A1
- 1771-EP2316834A1
- 1771-EP2371811A2
- 1771-EP2374454A1
- 5947-EP0930075A1
- 5947-EP2269994A1
- 5947-EP2289892A1
- 73M731
- A 6770
- A-2190
- A10021
- C01937
- D00142
- EN300-119523
- J10045
- Kyselina 4-amino-N(sup 10)-methylpteroylglutamova [Czech]
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- 4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid
- D005493
- Q422232
- SR-01000075682
- SR-01000597411
- W-60383
- A1204238
- I06-2098
- L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-
- N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
- SR-01000075682-1
- SR-01000075682-2
- SR-01000075682-6
- SR-01000597411-1
- (2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
- 2,2'-(9,10-anthracenediylidene)-bis-propanedinitrile
- BRD-K59456551-001-09-3
- BRD-K59456551-001-11-9
- BRD-K59456551-001-19-2
- BRD-K59456551-001-20-0
- BRD-K59456551-001-22-6
- I14-18123
- Methotrexate (1 mg/mL in Methanol with 0.1N NaOH)
- Methotrexate (1.0mg/mL in Methanol with 0.1N NaOH)
- N-(p-(((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid
- N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid
- Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova
- N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamicacid
- WLN: T66 BN DN GN JNJ CZ EZ H1N1&R DVMYVQ2VQ
- Z1521553982
- 4-AMINO-4-DEOXY-N(SUP 10)-METHYLPTEROYLGLUTAMATE
- Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-
- Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova [Czech]
- L-(+)-N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid
- N,N,N,N-ETHYLENEDIAMINETETRA(METHYLENEPHOSPHONICACID)
- N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-(+)-glutamic acid
- 4-AMINO-4-DEOXY-N(SUP 10)-METHYLPTEROYLGLUTAMIC ACID
- 60388-53-6
- Methotrexate, European Pharmacopoeia (EP) Reference Standard
- Amethopterin (hydrate); CL14377 (hydrate); WR19039 (hydrate)
- Methotrexate, United States Pharmacopeia (USP) Reference Standard
- N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid
- 51865-79-3
- Glutamic acid,4-diamino-6-pteridinyl)methyl] methylamino]benzoyl]-, L-(+)-
- L-Glutamic acid,4-diamino-6-pteridinyl)methyl]- methylamino]benzoyl]-
- N-[4-[(2,4-Diaminopteridin-6-yl)methyl(methyl)amino]benzoyl]glutamic acid
- N-[4-[[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-L-Glu-OH
- N-[4-[Methyl(2,4-diaminopteridin-6-ylmethyl)amino]benzoyl]-L-glutamic acid
- N-[4-[Methyl(2,4-diaminopteridin-6-ylmethyl)amino]benzoyl]glutamic acid
- N-[4-[Methyl[(2,4-diaminopteridin-6-yl)methyl]amino]benzoyl]glutamic acid
- (+)-N-[4-[N-(2,4-Diamino-6-pteridinylmethyl)methylamino]benzoyl]-L-glutamic acid
- (2S)-2-((4-((2,4-diaminopteridin-6-yl)methyl-methylamino)benzoyl)amino)pentanedioic acid
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
- (2S)-2-[[4-[Methyl[(2,4-diaminopteridin-6-yl)methyl]amino]benzoyl]amino]glutaric acid
- (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-L-glutamic acid
- (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)-(methyl)amino)benzamido)pentanedioic acid
- (S)-2-[4-[Methyl[(2,4-diaminopteridin-6-yl)methyl]amino]benzoylamino]pentanedioic acid
- 2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
- L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- [CAS]
- L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci)
- L-Glutamicacid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard
- Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard
- Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material
- N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamic acid
- N-(4-((2,4-Diaminopteridin-6-ylmethyl)(methyl)amino)benzoyl)-L-glutamic acid
- N-(4-{[(2,4-Diaminopteridin-1-Ium-6-Yl)methyl](Methyl)amino}benzoyl)-L-Glutamic Acid
- N-[4-[[(2,4-Diamino-6-pteridinyl)methyl] methylamino]benzoyl]-L-glutamic acid
- N-[4-[2,4-Diaminopteridine-6-ylmethyl(methyl)amino]benzoyl]-L-glutamic acid
- N-[p-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]-L-glutamic acid
- N-{4-[[(2,4-diaminopteridin-6-yl)methyl](methyl)amino]benzoyl}-L-glutamic acid
- (2S)-2-((4-(((2,4-DIAMINOPTERIDIN-6-YL)METHYL)(METHYL)AMINO)BENZOYL)AMINO)PENTANEDIOIC ACID
- (2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid;hydrate
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid;hydrate
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;hydrate
- (2S)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid;hydrate
- 102613-64-9
- 142155-43-9
- 200-413-8
- 70359-39-6
- GLUTAMIC ACID, N-(P-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)-, L-(+)-
- MT1
- N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid; L-(+)-N-[p-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-glutamic acid; (+)-Amethopterin; 4-Amino-10-methylfolic acid; 4-Amino-N10-methylfolic acid; 4-Amino-N10-methylpteroylglutamic acid; Amethopterin; Amethopterine; Antifolan; CL 14377; EMT 25299; Emtexate; L-Amethopterin; L-Methotrexate; Ledertrexate; MTX; Metatrexan; Methotrexat-Ebewe; Methotrexate; Methoxtrexate; Methylaminopterin; Mexate; N-[p-[[2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-(+)-glutamic acid; NSC 740; R 9985; Rheumatrex; Trexall